OIG memorandum report : drug compendia publishers maintain transparent processes for evaluating anticancer drug therapies and identifying potential conflicts.
(eBook)
Description
Also in this Series
More Details
Notes
Citations
United States. Department of Health and Human Services. Office of Inspector General. (2014). OIG memorandum report: drug compendia publishers maintain transparent processes for evaluating anticancer drug therapies and identifying potential conflicts . Department of Health and Human Services, Office of Inspector General.
Chicago / Turabian - Author Date Citation, 17th Edition (style guide)United States. Department of Health and Human Services. Office of Inspector General. 2014. OIG Memorandum Report: Drug Compendia Publishers Maintain Transparent Processes for Evaluating Anticancer Drug Therapies and Identifying Potential Conflicts. Department of Health and Human Services, Office of Inspector General.
Chicago / Turabian - Humanities (Notes and Bibliography) Citation, 17th Edition (style guide)United States. Department of Health and Human Services. Office of Inspector General. OIG Memorandum Report: Drug Compendia Publishers Maintain Transparent Processes for Evaluating Anticancer Drug Therapies and Identifying Potential Conflicts Department of Health and Human Services, Office of Inspector General, 2014.
MLA Citation, 9th Edition (style guide)United States. Department of Health and Human Services. Office of Inspector General. OIG Memorandum Report: Drug Compendia Publishers Maintain Transparent Processes for Evaluating Anticancer Drug Therapies and Identifying Potential Conflicts Department of Health and Human Services, Office of Inspector General, 2014.
Staff View
Grouping Information
| Grouped Work ID | efbf08a8-69ee-0cf0-1d59-aed85ba453fb-eng |
|---|---|
| Full title | oig memorandum report drug compendia publishers maintain transparent processes for evaluating anticancer drug therapies and identifying potential conflicts |
| Author | united states department of health and human servi |
| Grouping Category | book |
| Last Update | 2023-05-05 15:45:20PM |
| Last Indexed | 2024-04-21 01:18:25AM |
Book Cover Information
| Image Source | default |
|---|---|
| First Loaded | Sep 11, 2022 |
| Last Used | Jan 26, 2024 |
Marc Record
| First Detected | Jun 13, 2016 12:00:00 AM |
|---|---|
| Last File Modification Time | May 05, 2023 03:51:51 PM |
MARC Record
| LEADER | 02013cam a2200433 i 4500 | ||
|---|---|---|---|
| 001 | ocn951607615 | ||
| 003 | OCoLC | ||
| 005 | 20160613090423.0 | ||
| 006 | m o d f | ||
| 007 | cr m|||||||||| | ||
| 008 | 160613s2014 dcua ob f000 0 eng c | ||
| 040 | |a GPO|b eng|e rda|e pn|c GPO|d MvI | ||
| 042 | |a pcc | ||
| 043 | |a n-us--- | ||
| 074 | |a 0445-B-07 (online) | ||
| 086 | 0 | |a HE 1.75:OEI-07-13-00220 | |
| 088 | |a OEI-07-13-00220 | ||
| 099 | |a HE 1.75:OEI-07-13-00220 | ||
| 110 | 1 | |a United States.|b Department of Health and Human Services.|b Office of Inspector General,|e author. | |
| 245 | 1 | 0 | |a OIG memorandum report :|b drug compendia publishers maintain transparent processes for evaluating anticancer drug therapies and identifying potential conflicts. |
| 246 | 3 | 0 | |a Office of Inspector General memorandum report:|b drug compendia publishers maintain transparent processes for evaluating anticancer drug therapies and identifying potential conflicts |
| 246 | 3 | 0 | |a Drug compendia publishers maintain transparent processes for evaluating anticancer drug therapies and identifying potential conflicts |
| 246 | 1 | |i Running title:|a Drug compendia publishers maintain transparent processes | |
| 264 | 1 | |a Washington, DC :|b Department of Health and Human Services, Office of Inspector General,|c 2014. | |
| 300 | |a 1 online resource (5 pages) :|b illustrations | ||
| 336 | |a text|2 rdacontent | ||
| 337 | |a computer|2 rdamedia | ||
| 338 | |a online resource|2 rdacarrier | ||
| 500 | |a Title from title screen (viewed June 13, 2016). | ||
| 500 | |a "Oct[ober] 30 2014." | ||
| 500 | |a "OEI-07-13-00220." | ||
| 500 | |a GPO Cataloging Record Distribution Program (CRDP). | ||
| 504 | |a Includes bibliographical references. | ||
| 650 | 0 | |a Medical publishing|x Standards|z United States. | |
| 650 | 0 | |a Conflict of interests. | |
| 650 | 0 | |a Cancer|x Treatment|z United States|x Evaluation. | |
| 650 | 0 | |a Drugs|z United States|x Testing. | |
| 856 | 4 | 0 | |u https://purl.fdlp.gov/GPO/gpo68643 |
| 949 | |a HE 1.75:OEI-07-13-00220|t x | ||